| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.28M | -119,250 | |
| Other | 755.5K | $4.06M | -29,131 | |
| Dir | 613.6K | $3.30M | - | |
| CFO | 554.5K | $2.98M | -41,884 | |
| COO | 497.8K | $2.68M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2020 | Sabzevari Helen75 | President And CEO | Sale+OE | 3,886 | $5.77 | $22,421.44 | -4.3% | |
| Jan 3, 2020 | Reed Thomas D. | Chief Science Officer | Sale+OE | 2,986 | $5.77 | $17,228.92 | -2.2% | |
| Jan 3, 2020 | Bostick Thomas | Chief Operating Officer | Sale+OE | 3,564 | $5.77 | $20,563.57 | -5.4% | |
| Jan 3, 2020 | Lehr Donald P.75 | Chief Legal Officer | Sale+OE | 3,886 | $5.77 | $22,421.83 | -4.5% | |
| Jan 3, 2020 | Perez Jeffrey Thomas71 | SVP, Ip Affairs | Sale+OE | 3,564 | $5.77 | $20,563.57 | -4.9% | |
| Jan 2, 2020 | Sabzevari Helen75 | President And CEO | Sale+OE | 4,830 | $5.60 | $27,048.00 | -5.6% | |
| Jan 2, 2020 | Reed Thomas D. | Chief Science Officer | Sale+OE | 3,533 | $5.60 | $19,784.80 | -2.7% | |
| Jan 2, 2020 | Perez Jeffrey Thomas71 | SVP, Ip Affairs | Sale+OE | 4,366 | $5.60 | $24,449.60 | -6.5% | |
| Jan 2, 2020 | Lehr Donald P.75 | Chief Legal Officer | Sale+OE | 4,830 | $5.60 | $27,048.00 | -6.0% | |
| Jan 2, 2020 | Bostick Thomas | Chief Operating Officer | Sale+OE | 4,366 | $5.60 | $24,449.60 | -7.3% |